KMPharmaceutical Co. Ltd.
KMPharmaceutical Co. Ltd. operates in Soft Drinks & Non-alcoholic Beverages.
Market Cap & Net Worth: KMPharmaceutical Co. Ltd. (225430)
KMPharmaceutical Co. Ltd. (KO:225430) has a market capitalization of $2.53K (₩3.70 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #46917 globally and #2666 in its home market, demonstrating a 5.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying KMPharmaceutical Co. Ltd.'s stock price ₩401.00 by its total outstanding shares 9228 (9.23K).
KMPharmaceutical Co. Ltd. Market Cap History: 2015 to 2026
KMPharmaceutical Co. Ltd.'s market capitalization history from 2015 to 2026. Data shows change from $11.99K to $2.53K (-14.31% CAGR).
KMPharmaceutical Co. Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how KMPharmaceutical Co. Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 225430 by Market Capitalization
Companies near KMPharmaceutical Co. Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to KMPharmaceutical Co. Ltd. by market ranking:
- Bifido Co. Ltd. (KO:238200): Ranked #43968 globally with a market cap of $18.30K USD ( ₩26.80 Million KRW).
- ICure Pharm Inc. (KO:175250): Ranked #44422 globally with a market cap of $13.74K USD ( ₩20.11 Million KRW).
- ARCTIC BIOSCIENCE NK -10 (F:9TD): Ranked #46918 globally with a market cap of $2.57K USD ( €2.51K EUR).
- HOTELEST LTD (SEM:HTLS): Ranked #46919 globally with a market cap of $2.57K USD ( MURs121.20K MUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #43968 | Bifido Co. Ltd. | KO:238200 | $18.30K | ₩2895.00 |
| #44422 | ICure Pharm Inc. | KO:175250 | $13.74K | ₩2170.00 |
| #46918 | ARCTIC BIOSCIENCE NK -10 | F:9TD | $2.57K | €0.26 |
| #46919 | HOTELEST LTD | SEM:HTLS | $2.57K | MURs13.05 |
KMPharmaceutical Co. Ltd. Historical Marketcap From 2015 to 2026
Between 2015 and today, KMPharmaceutical Co. Ltd.'s market cap moved from $11.99K to $ 2.53K, with a yearly change of -14.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩2.53K | -25.46% |
| 2025 | ₩3.39K | -21.46% |
| 2024 | ₩4.32K | -29.96% |
| 2023 | ₩6.16K | -38.49% |
| 2022 | ₩10.02K | -28.54% |
| 2021 | ₩14.02K | -23.67% |
| 2020 | ₩18.37K | +10.03% |
| 2019 | ₩16.70K | -5.75% |
| 2018 | ₩17.72K | +49.24% |
| 2017 | ₩11.87K | -0.75% |
| 2016 | ₩11.96K | -0.25% |
| 2015 | ₩11.99K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of KMPharmaceutical Co. Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.53K USD |
| MoneyControl | $2.53K USD |
| MarketWatch | $2.53K USD |
| marketcap.company | $2.53K USD |
| Reuters | $2.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.